H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to Clopidogrel

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The purpose of this study was to assess whether interpatient variability in the platelet response to clopidogrel is partly due to polymorphisms of the hepatic cytochrome P450 (CYP450)3A and of the clopidogrel-P2Y12 receptor genes.
Epistemonikos ID: 65ca7c493076236088207c02cc6f3b4ba4f185ad
First added on: May 04, 2024